Published in J Clin Microbiol on September 01, 2006
The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol (2012) 3.88
High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol (2011) 3.11
The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology (2014) 2.73
Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients (2012) 2.10
Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther (2010) 1.73
The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg (2010) 1.69
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol (2010) 1.41
Immunopathology of inflammatory bowel disease. World J Gastroenterol (2014) 1.36
Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis. Gut (2007) 1.29
Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis. Clin Dev Immunol (2013) 1.29
Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice. Inflamm Bowel Dis (2008) 1.16
Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement Altern Med (2010) 1.11
Host responses to intestinal microbial antigens in gluten-sensitive mice. PLoS One (2009) 1.08
Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLoS One (2013) 1.03
Current status and prospects of intestinal microbiome studies. Intest Res (2014) 1.02
PCR-TTGE analysis of 16S rRNA from rainbow trout (Oncorhynchus mykiss) gut microbiota reveals host-specific communities of active bacteria. PLoS One (2012) 1.02
A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease. BMC Microbiol (2009) 0.98
An efficient RNA extraction method for estimating gut microbial diversity by polymerase chain reaction. Curr Microbiol (2009) 0.96
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int (2013) 0.95
Genome-Wide Association Studies of the Human Gut Microbiota. PLoS One (2015) 0.93
Application of sequence-dependent electrophoresis fingerprinting in exploring biodiversity and population dynamics of human intestinal microbiota: what can be revealed? Interdiscip Perspect Infect Dis (2008) 0.87
The bacterial pathogenesis and treatment of pouchitis. Therap Adv Gastroenterol (2010) 0.86
Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice. Dig Dis Sci (2016) 0.85
Blueberry husks and probiotics attenuate colorectal inflammation and oncogenesis, and liver injuries in rats exposed to cycling DSS-treatment. PLoS One (2012) 0.84
Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid. Indian J Med Res (2015) 0.84
Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India. J Gastroenterol (2016) 0.84
Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitis. Gut Pathog (2012) 0.83
Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis. World J Gastroenterol (2010) 0.83
Intestinal Host-Microbe Interactions under Physiological and Pathological Conditions. Int J Inflam (2010) 0.83
Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease. BMC Genomics (2011) 0.83
Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis. World J Gastroenterol (2014) 0.82
Microbiome, Metabolome and Inflammatory Bowel Disease. Microorganisms (2016) 0.78
Colorectal Oncogenesis and Inflammation in a Rat Model Based on Chronic Inflammation due to Cycling DSS Treatments. Gastroenterol Res Pract (2011) 0.78
Treatment of inflammatory bowel disease associated E. coli with ciprofloxacin and E. coli Nissle in the streptomycin-treated mouse intestine. PLoS One (2011) 0.77
Correlations of Host Genetics and Gut Microbiome Composition. Front Microbiol (2016) 0.77
Clinical detection of human probiotics and human pathogenic bacteria by using a novel high-throughput platform based on next generation sequencing. J Clin Bioinforma (2014) 0.77
Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin. Gut Microbes (2015) 0.76
Impact of a Recombinant Biocontrol Bacterium, Pseudomonas fluorescens pc78, on Microbial Community in Tomato Rhizosphere. Plant Pathol J (2016) 0.75
Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases. Clin Transl Immunology (2017) 0.75
Sex differences in colonization of gut microbiota from a man with short-term vegetarian and inulin-supplemented diet in germ-free mice. Sci Rep (2016) 0.75
Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies. Pharmgenomics Pers Med (2017) 0.75
Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol (1999) 16.09
Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (2002) 13.83
Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol (1998) 10.67
rrndb: the Ribosomal RNA Operon Copy Number Database. Nucleic Acids Res (2001) 9.36
Mucosal flora in inflammatory bowel disease. Gastroenterology (2002) 8.42
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology (2004) 5.94
Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc Natl Acad Sci U S A (2002) 5.40
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut (2004) 5.32
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut (2003) 5.19
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology (2004) 5.19
Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology (1998) 5.02
Dysbiosis in inflammatory bowel disease. Gut (2004) 5.01
Escherichia fergusonii and Enterobacter taylorae, two new species of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol (1985) 4.52
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut (2004) 3.80
Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis (2005) 2.93
Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis (2005) 2.47
NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun (2004) 2.47
Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis (2006) 2.45
Comparative study of bacterial groups within the human cecal and fecal microbiota. Appl Environ Microbiol (2001) 2.17
Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains. J Bacteriol (2005) 2.01
Escherichia albertii sp. nov., a diarrhoeagenic species isolated from stool specimens of Bangladeshi children. Int J Syst Evol Microbiol (2003) 2.01
The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut (2000) 1.65
Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun (2000) 1.49
Enteropathogenicity and antimicrobial susceptibility of new Escherichia spp. J Diarrhoeal Dis Res (1999) 1.37
Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut (1992) 1.30
Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J Gastroenterol Hepatol (2000) 1.21
Verocytotoxin-producing Escherichia coli O2:H5 isolated from patients with ulcerative colitis. Lancet (1989) 1.03
Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol (1999) 16.09
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut (2005) 10.95
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut (2003) 5.19
Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis (2009) 4.72
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol (2009) 3.58
ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat Genet (2000) 3.17
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology (2000) 2.78
Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics (1999) 2.69
Postnatal transmission of HIV from mother to child. Lancet (1987) 2.60
Insect immunity: isolation from immune blood of the dipteran Phormia terranovae of two insect antibacterial peptides with sequence homology to rabbit lung macrophage bactericidal peptides. Proc Natl Acad Sci U S A (1989) 2.49
Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther (2014) 2.42
Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst Appl Microbiol (2001) 2.23
Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet (1993) 2.18
Comparative study of bacterial groups within the human cecal and fecal microbiota. Appl Environ Microbiol (2001) 2.17
Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol (2005) 2.16
European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis (2008) 2.14
The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease. Aliment Pharmacol Ther (2014) 2.09
Acquired immunodeficiency syndrome in Rwanda. Lancet (1984) 2.05
Demonstration of safety of probiotics -- a review. Int J Food Microbiol (1998) 2.02
Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia (2011) 2.00
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther (2006) 1.97
Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Aliment Pharmacol Ther (2000) 1.88
Recovery and phylogenetic analysis of archaeal rRNA sequences from continental shelf sediments. FEMS Microbiol Lett (1998) 1.84
Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains. J Immunol (1996) 1.78
Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii. Proc Natl Acad Sci U S A (1989) 1.73
Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis (2003) 1.72
Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm Bowel Dis (2010) 1.70
Association of chronic interstitial cystitis, protein-losing enteropathy and paralytic ileus with seronegative systemic lupus erythematosus: case report and review of the literature. Clin Nephrol (1992) 1.66
Community-acquired bacteraemia in African children. Lancet (1987) 1.61
Long-term outcome of patients with gastrointestinal bleeding of obscure origin explored by push enteroscopy. Endoscopy (2002) 1.60
Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol (2000) 1.59
Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect? Gut (1997) 1.55
Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am J Clin Nutr (1992) 1.54
Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia. J Lipid Res (2000) 1.46
Validation of a live animal model for training in endoscopic hemostasis of upper gastrointestinal bleeding ulcers. Endoscopy (2013) 1.46
Cryptosporidium spp., a frequent cause of diarrhea in Central Africa. J Clin Microbiol (1984) 1.44
Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br J Nutr (2002) 1.39
[Code of professional ethics in clinical research]. Gastroenterol Clin Biol (2001) 1.39
Review article: gut flora and inflammatory bowel disease. Aliment Pharmacol Ther (2004) 1.36
Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practice. The Ghent International Working Group on Mother-To-Child Transmission of HIV. Health Policy Plan (2000) 1.34
Effects of gold salts and prednisolone on inflammatory cells. II. Suppression of inflammation and phagocytosis in the rat. Ann Rheum Dis (1973) 1.33
A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome in Africa. Am J Ophthalmol (1985) 1.33
Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda. Pediatrics (1993) 1.33
A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl Microbiol Biotechnol (1999) 1.31
Breastfeeding and hospital mortality in children in Rwanda. Lancet (1981) 1.30
Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis. Gut (2007) 1.29
Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda. J Infect Dis (1991) 1.29
Seroincidence of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988-1992. AIDS (1994) 1.28
Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr (1999) 1.26
Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil (2012) 1.25
On the safety of lactic acid bacteria from food. Int J Food Microbiol (1995) 1.25
Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk. Gastroenterology (1992) 1.24
Molecular phylogenetic profiling of prokaryotic communities in guts of termites with different feeding habits. FEMS Microbiol Ecol (2001) 1.22
Reducing weight increases postural stability in obese and morbid obese men. Int J Obes (Lond) (2006) 1.22
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies. Aliment Pharmacol Ther (2010) 1.18
Interrelations between populations of methanogenic archaea and sulfate-reducing bacteria in the human colon. FEMS Microbiol Lett (1992) 1.18
Dysbiosis in inflammatory bowel disease: a role for bacteriophages? Gut (2008) 1.18
Genomic structure, promoter sequence, and induction of expression of the mouse Nramp1 gene in macrophages. Genomics (1995) 1.18
Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology (Oxford) (2002) 1.16
Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil (2013) 1.13
Cloning and nucleotide sequence of the phosphoenolpyruvate carboxylase-coding gene of Corynebacterium glutamicum ATCC13032. Gene (1989) 1.11
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut (2007) 1.09
Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol (2011) 1.09
Altered secretion in the right colon during ulcerative colitis: is it due to disease or to 5-ASA? Neurogastroenterol Motil (2013) 1.09
Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie (1998) 1.07
Whole exome sequencing unravels disease-causing genes in consanguineous families in Qatar. Clin Genet (2013) 1.06
Lactose intolerance. J Am Coll Nutr (2000) 1.06
Ecological study of a bioaugmentation failure. Environ Microbiol (2000) 1.05
High-resolution linkage map in the proximity of the host resistance locus Cmv1. Genomics (1997) 1.05
The contribution of lysine-36 to catalysis by human myo-inositol monophosphatase. Biochemistry (1996) 1.04
Mother-to-infant transmission of human immunodeficiency virus by breast milk: presumed innocent or presumed guilty? Clin Infect Dis (1992) 1.02
Probiotics and intestinal health effects: a clinical perspective. Br J Nutr (2002) 1.00
Four years of natural history of HIV-1 infection in african women: a prospective cohort study in Kigali (Rwanda), 1988-1993. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.00
Video capsule endoscopy for investigation of obscure gastrointestinal bleeding: feasibility, results, and interobserver agreement. Endoscopy (2005) 0.99
Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease. Gut (2009) 0.99
Spectrum and frequency of illness presenting to a pediatric emergency department. Acta Clin Belg (2006) 0.99
A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol (2008) 0.98
Mast cell numbers in incisional wounds in rat skin as a function of distance, time and treatment. Br J Dermatol (1983) 0.98
Severe multiresistant Salmonella typhimurium systemic infections in Central Africa--clinical features and treatment in a paediatric department. J Antimicrob Chemother (1984) 0.97
Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis. J Crohns Colitis (2009) 0.96
Mucolipidosis II: a single causal mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder population. Clin Genet (2008) 0.95
Gastrointestinal tract and the elderly: functional foods, gut microflora and healthy ageing. Dig Liver Dis (2002) 0.95
Gastroileal nitrogen and electrolyte movements after bovine milk ingestion in humans. Am J Clin Nutr (1992) 0.95